Literature DB >> 28215830

Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele.

Cristian Sager1, Carol Burek2, Juan Pablo Corbetta2, Santiago Weller2, Javier Ruiz2, Ramiro Perea2, Enrique Lago2, Yesica Gomez2, Victor Durán2, Juan Carlos López2.   

Abstract

INTRODUCTION: The proactive management of children with myelomeningocele (MMC) has contributed to decreasing their progression to end-stage renal disease, thanks to early urological evaluation and timing implementation of treatments.
OBJECTIVE: To demonstrate that early urological evaluation of the urinary tract in MMC shows functional alterations in most cases, and that it requires medical intervention, even when in some cases the complementary imaging studies do not show any abnormalities.
MATERIAL AND METHODS: A retrospective study including 60 patients aged <1 year with MMC who were followed by a multidisciplinary team. All of them underwent renal/bladder ultrasound, videourodynamic studies, renal scintigraphy/dimercaptosuccinic acid (DMSA), and laboratory tests for kidney function. The studied variables were: bladder capacity and pressure, presence of overactivity, vesicoureteral reflux (VUR), urinary dilations and abnormalities on renal scintigraphy/DMSA. All the patients received clean intermittent catheterization (CIC).
RESULTS: See Summary Table all the patients showed alterations in at least some of the assessed urodynamic variables: reduced cystometric capacity, 21.6%; detrusor overactivity, 55%; end filling detrusor pressure >20 cm H2O, 43.3%; inefficient bladder voiding, 98.3%; indirect dyssynergic patterns, 28.8%. The high-risk videourodynamic findings were observed in 28 cases (46.6%). DMSA was abnormal in 30%. Renal impairment was detected in 6.6% of cases. A total of 66% of cases received oxybutynin. DISCUSSION: Almost all the children in this sample population showed urinary dysfunction, and approximately half of them had high-risk videourodynamic findings. Although many cases showed reflex urinary contractions, almost the entire sample had inefficient bladder voiding. An important limitation of this work was the lack of simultaneity in obtaining each of the requested studies.
CONCLUSIONS: In the initial urological evaluation of patients with myelomeningocele, almost all the urodynamic studies showed abnormalities and one-third showed abnormal DMSA, which led to therapeutic actions being initiated, although imaging studies were normal in a great number of patients. CIC alone, starting immediately after birth, is not sufficient. To eliminate or decrease upper tract damage, oxybutynin should be started in addition.
Copyright © 2017 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Myelomeningocele; Neurogenic bladder; Videourodynamics

Mesh:

Year:  2017        PMID: 28215830     DOI: 10.1016/j.jpurol.2016.12.024

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  3 in total

1.  Baseline Urinary Tract Imaging in Infants Enrolled in the UMPIRE Protocol for Children with Spina Bifida.

Authors:  Stacy T Tanaka; Pangaja Paramsothy; Judy Thibadeau; John S Wiener; David B Joseph; Earl Y Cheng; Duong Tu; Christopher Austin; Chester J Koh; M Chad Wallis; William O Walker; Kathryn A Smith; Jonathan C Routh; Michelle A Baum
Journal:  J Urol       Date:  2019-06       Impact factor: 7.450

2.  Zika-Related Microcephaly and Its Repercussions for the Urinary Tract: Clinical, Urodynamic, Scintigraphic and Radiological Aspects.

Authors:  Rômulo Augusto Lucena de Vasconcelos; Ricardo Arraes de Alencar Ximenes; Adriano Almeida Calado; Celina Maria Turchi Martelli; Andreia Veras Gonçalves; Elizabeth Bailey Brickley; Thalia Velho Barreto de Araújo; Maria Angela Wanderley Rocha; Demócrito de Barros Miranda-Filho
Journal:  Viruses       Date:  2022-07-11       Impact factor: 5.818

3.  In utero myelomeningocele repair and high-risk bladder pattern. a prospective study.

Authors:  Antonio Macedo; Sérgio Leite Ottoni; Antonio Moron; Sergio Cavalheiro; Marcela Leal da Cruz
Journal:  Int Braz J Urol       Date:  2022 Jul-Aug       Impact factor: 3.050

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.